$4550
$2730
The Superdisintegrants market was valued at US$ 369.56million in 2019 and it is projected to reach US$ 659.17 million by 2027; it is expected to grow at a CAGR of 7.6% from 2020 to 2027.
The superdisintegrants are the agents that are mixed in the tablets to intensify the breakup of the tablet into small fragments in aqueous conditions, thereby boosting the release of the drug into the body. In past years superdisintegrants have gained the attention of the pharmaceutical industry as it increases the solubility of active pharmaceutical ingredient (API) in the body by raising the absorption of the drug in the body due to which bioavailability of drugs also increases. The superdisintegrant agent is used in tablets and capsules. The growth of the Superdisintegrants market is attributed to the growing adoption of orally disintegrating solid dosage forms across the globe and increasing acceptability of generic drugs are expected to boost the market growth over the years. However, high cost associated with the manufacturing of superdisintegrants is likely to have a negative impact on the growth of the market in the coming years.
The Superdisintegrants market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.
Lucrative Regions for Superdisintegrants Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Growing Applications of Superdisintegrants in Healthcare to Drive Superdisintegrants Market Growth
The world is witnessing exponential growth in the prevalence of chronic diseases. Factors such as progression of viruses, bacteria, parasites, coupled with growing adoption of sedentary lifestyle, genetic conditions, and consumption of poor diet are responsible for the growing prevalence of these diseases. This exponential increase in the prevalence of diseases is leading to the adoption of solid dosage forms for disease treatment. For instance, according to data published by the World Health Organization (WHO) in 2019, an estimated 71.0 million people suffer from hepatitis C virus infection across the world. Oral drug delivery remains the most common route of drug administration in the healthcare world. Solid dosage forms typically includes tablets, capsules, and powders for the treatment of particular disease condition. Moreover, growing emphasis on novel drug delivery approach is expected to boost the awareness and focus on the utilization of orally disintegrating tablets during the forecast period. Superdisintegrants or orally disintegrating tablets are gaining traction due to advantages such as ease of drug administration and better compliance for pediatric and geriatric patients. Furthermore, superdisintegrant tablets offer several benefits over traditional capsules and tablets. Advantages of disintegrants include the ability for accurate dosing, fast action, superior patient compliance, better palatability, and cost effectiveness, as well as ease of administration, no risk of airway suffocation during swallowing, and flexibility in terms of large and small molecules. Such salient features of superdisintegrant tablets represent massive potential for its adoption during tablet formulations. Moreover, on-going research and development activities conducted by major players and research institutes are likely to expand the range of benefits offered by superdisintegrants during the forecast period. Additionally, the increasing adoption of orally disintegrating tablets is attributable to new product launches by several pharmaceuticals companies. For instance, in April 2018, the partnership of Perrigo Company Plc. and Dexcel Pharma Technologies Ltd. launched Omeprazole ODT—orally disintegrating tablets to treat heartburn. The company took strategic step to expand geriatric customer base.
Generic drugs refer to qualitative and quantitative compositions of active components whose bioequivalence has been demonstrated by suitable bioavailability studies. Cost efficiency is the prominent factor that is driving the acceptance and adoption of generic drugs across the world. For instance, according to the study published in Journal of Pharmaceutical Health Care and Sciences (2015), nearly 50.0–60.0% of drug use across the world was of generic drugs. Certain benefits such as superior treatment outcomes, cost benefits, and easy availability played a major part in higher consumption of generic medications. Such higher consumption of generic medications is directly correlated to increased manufacturing of drugs. Moreover, increasing popularity of orally disintegrating drugs is likely to drive the usage of superdisintegrants in generic drugs, which will ultimately drive the growth of the global superdisintegrants market during the forecast period. Additionally, majority of the governments across the world are also implementing strategic policies to encourage the use of generic drugs. For instance, in 2016, the Medical Council of India, recommended physicians to include generic drugs in pharmacy prescriptions to fuel the utilization of generic drugs in the country. As generic drugs are cheaper by about 30.0–80.0%, the government is focusing to increase its adoption with an aim to expand the reach of drugs to every financial class.
Type-Based Insights
In terms of type, the Superdisintegrants market is segmented into synthetic superdisintegrants, natural superdisintegrants, and others. In 2019, the synthetic superdisintegrant segment held the largest share of the market.
Superdisintegrants Market, by Type – 2019 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Formulation-Based Insights
Based on formulation, the Superdisintegrants market is segmented into tablets and capsules. In 2019, the tablets segment held the largest share of the market.
Therapeutic Area-Based Insights
In terms of therapeutic area, the Superdisintegrants market is segmented into into neurological diseases, gastrointestinal diseases, oncology, inflammatory diseases, infectious diseases, cardiovascular diseases, and other diseases. In 2019, the gastrointestinal diseases segment held the largest share of the market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Superdisintegrants Market: Strategic Insights
Market Size Value in US$ 369.56 Million in 2019 Market Size Value by US$ 659.17 Million by 2027 Growth rate CAGR of 7.6% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Superdisintegrants Market: Strategic Insights
Market Size Value in | US$ 369.56 Million in 2019 |
Market Size Value by | US$ 659.17 Million by 2027 |
Growth rate | CAGR of 7.6% from 2020-2027 |
Forecast Period | 2020-2027 |
Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to AnalystThe Superdisintegrants market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.
Superdisintegrants Market – by Type
- Synthetic Superdisintegrants
- Crospovidone
- Modified Starch
- Modified Cellulose
- Calcium Silicates
- Ion Exchange Resins
- Natural Superdisintegrants
- Other Superdisintegrants
Superdisintegrants Market – by Formulation
- Tablets
- Capsules
Superdisintegrants Market – by Therapeutic Area
- Neurological Diseases
- Gastrointestinal Diseases
- Oncology
- Inflammatory Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Other Diseases
Superdisintegrants Market – by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South America and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Ashland
- BASF SE
- DowDupont Inc.
- JRS PHARMA
- COREL PHARMA CHEM
- Roquette Frères
- Asahi Kasei Corporation
- Merck KGaA
- Avantor, Inc.
- DFE Pharma
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type ; Formulation ; Therapeutic Area , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The superdisintegrants are the agents that are mixed in the tablets to intensify the breakup of the tablet into small fragments in aqueous conditions, thereby boosting the release of the drug into the body. In past years superdisintegrants have gained the attention of the pharmaceutical industry as it increases the solubility of active pharmaceutical ingredient (API) in the body by raising the absorption of the drug in the body due to which bioavailability of drugs also increases. The superdisintegrant agent is used in tablets and capsules.
Growing adoption of orally disintegrating solid dosage forms across the globe and increasing the acceptability of generic drugs is expected to boost market growth over the years. Moreover, emerging pharmaceuticals markets in developing countries are anticipated to provide opportunities for the global market.
Certain techniques such as tablet molding, spray drying, cotton candy process, and freeze-drying are incorporated during the production of superdisintegrants. Installation and maintenance of machinery equipment incur substantial costs burdens on market players. Therefore, the high cost associated with the manufacturing of superdisintegrants is likely to harm the growth of the market in the coming years.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Superdisintegrants Market – By Type
1.3.2 Global Superdisintegrants Market – By Formulation
1.3.3 Global Superdisintegrants Market – By Therapeutic Area
1.3.4 Global Superdisintegrants Market – By Application
1.3.5 Global Superdisintegrants Market – By Geography
2. Superdisintegrants Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Superdisintegrants – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Superdisintegrants Market in North America: PEST Analysis
4.2.2 Superdisintegrants Market in Europe: PEST Analysis
4.2.3 Superdisintegrants Market in APAC: PEST Analysis
4.2.4 Superdisintegrants Market in MEA: PEST Analysis
4.2.5 Superdisintegrants Market – South and Central America PEST Analysis
4.3 Expert Opinion
5. Superdisintegrants Market – Key Dynamics
5.1 Drivers
5.1.1 Growing Adoption of Orally Disintegrating Drugs
5.1.2 Increasing Acceptability of Generic Drugs
5.2 Restraints
5.2.1 High Cost Associated with Manufacturing of Superdisintegrants
5.3 Opportunities
5.3.1 Emerging Pharmaceuticals Markets in Developing Countries
5.4 Trends
5.4.1 Growing Emphasis on Adoption of Novel Drug Delivery Systems
5.5 Impact Analysis
6. Superdisintegrants Market – Global Analysis
6.1 Global Superdisintegrants Market Revenue Forecast And Analysis
6.2 Global Superdisintegrants Market, By Geography - Forecast And Analysis
6.3 Positioning Of Key Players
6.3.1 DowDupont Inc.
6.3.2 Ashland
7. Superdisintegrants Market Analysis and Forecasts to 2027 – Type
7.1 Overview
7.2 Global Superdisintegrants, by Type, 2019 & 2027 (% Share)
7.3 Synthetic Superdisintegrants
7.3.1 Overview
7.3.2 Global Synthetic Superdisintegrants Market Revenue and Forecast to 2027 (US$ Mn)
7.3.2.1 Crospovidone Market
7.3.2.1.1 Overview
7.3.2.1.2 Global Crospovidone Market Revenue and Forecast to 2027 (US$ Mn)
7.3.2.2 Modified Starch Market
7.3.2.2.1 Overview
7.3.2.2.2 Global Modified Starch Market Revenue and Forecast to 2027 (US$ Mn)
7.3.2.3 Modified Cellulose Market
7.3.2.3.1 Overview
7.3.2.3.2 Global Modified Cellulose Market Revenue and Forecast to 2027 (US$ Mn)
7.3.2.4 Calcium Silicates Market
7.3.2.4.1 Overview
7.3.2.4.2 Global Calcium Silicates Market Revenue and Forecast to 2027 (US$ Mn)
7.3.2.5 Ion Exchange Resins Market
7.3.2.5.1 Overview
7.3.2.5.2 Global Ion Exchange Resins Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Natural Superdisintegrants
7.4.1 Overview
7.4.2 Global Natural Superdisintegrants Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Other Superdisintegrants
7.5.1 Overview
7.5.2 Global Other Superdisintegrants Market Revenue and Forecast to 2027 (US$ Mn)
8. Superdisintegrants Market Analysis and Forecasts to 2027 – Formulation
8.1 Overview
8.2 Global Superdisintegrants Market, by Formulation, 2019 & 2027 (% Share)
8.3 Tablets
8.3.1 Overview
8.3.2 Global Tablets Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Capsules
8.4.1 Overview
8.4.2 Global Capsules Market Revenue and Forecast to 2027 (US$ Mn)
9. Superdisintegrants Market Analysis and Forecasts to 2027 – Therapeutic Area
9.1 Overview
9.2 Global Superdisintegrants Market, by Therapeutic Area, 2019 & 2027 (% Share)
9.3 Neurological Diseases
9.3.1 Overview
9.3.2 Global Neurological Diseases Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Gastrointestinal Diseases
9.4.1 Overview
9.4.2 Global Gastrointestinal Diseases Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Oncology
9.5.1 Overview
9.5.2 Global Oncology Market Revenue and Forecast to 2027 (US$ Mn)
9.6 Inflammatory Diseases
9.6.1 Overview
9.6.2 Global Inflammatory Diseases Market Revenue and Forecast to 2027 (US$ Mn)
9.7 Infectious Diseases
9.7.1 Overview
9.7.2 Global Infectious Diseases Market Revenue and Forecast to 2027 (US$ Mn)
9.8 Cardiovascular Diseases
9.8.1 Overview
9.8.2 Global Cardiovascular Diseases Market Revenue and Forecast to 2027 (US$ Mn)
9.9 Others
9.9.1 Overview
9.9.2 Global Others Market Revenue and Forecast to 2027 (US$ Mn)
10. Superdisintegrants Market Analysis and Forecasts to 2027 – Application
10.1 Overview
10.2 Global Superdisintegrants Market, by Application, 2019 & 2027 (% Share)
10.3 Pharmaceuticals
10.3.1 Overview
10.3.2 Global Pharmaceuticals Market Revenue and Forecast to 2027 (US$ Mn)
10.4 Nutraceuticals
10.4.1 Overview
10.4.2 Global Nutraceuticals Market Revenue and Forecast to 2027 (US$ Mn)
11. Superdisintegrants Market – Geographic Analysis
11.1 North America Superdisintegrants Market, Revenue and Forecast to 2027
11.1.1 Overview
11.1.2 North America Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
11.1.3 North America Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.1.3.1 North America Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.1.4 North America Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
11.1.5 North America Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11.1.6 North America Superdisintegrants Market, Revenue and Forecast to 2027, by Application (US$ Mn)
11.1.7 North America Superdisintegrants Market, Revenue and Forecast to 2027, By Country (%)
11.1.8 US
11.1.8.1 US Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
11.1.8.2 US Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.1.8.2.1 US Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.1.8.3 US Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
11.1.8.4 US Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11.1.8.5 US Superdisintegrants Market, Revenue and Forecast to 2027, by Application (US$ Mn)
11.1.9 Canada
11.1.9.1 Canada Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
11.1.9.2 Canada Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.1.9.2.1 Canada Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.1.9.3 Canada Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
11.1.9.4 Canada Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11.1.9.5 Canada Superdisintegrants Market, Revenue and Forecast to 2027, by Application (US$ Mn)
11.1.10 Mexico
11.1.10.1 Mexico Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
11.1.10.2 Mexico Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.1.10.2.1 Mexico Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.1.10.3 Mexico Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
11.1.10.4 Mexico Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11.1.10.5 Mexico Superdisintegrants Market, Revenue and Forecast to 2027, by Application (US$ Mn)
11.2 Europe Superdisintegrants Market, Revenue and Forecast To 2027
11.2.1 Overview
11.2.2 Europe Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
11.2.3 Europe Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.2.3.1 Europe Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.2.4 Europe Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
11.2.5 Europe Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11.2.6 Europe Superdisintegrants Market, Revenue and Forecast to 2027, by Application (US$ Mn)
11.2.7 Europe Superdisintegrants Market, Revenue and Forecast to 2027, By Country (%)
11.2.8 Germany
11.2.8.1 Germany Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
11.2.8.2 Germany Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.2.8.2.1 Germany Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.2.8.3 Germany Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
11.2.8.4 Germany Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11.2.8.5 Germany Superdisintegrants Market, Revenue and Forecast to 2027, by Application (US$ Mn)
11.2.9 UK
11.2.9.1 UK Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
11.2.9.2 UK Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.2.9.2.1 UK Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.2.9.3 UK Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
11.2.9.4 UK Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11.2.9.5 UK Superdisintegrants Market, Revenue and Forecast to 2027, by Application (US$ Mn)
11.2.10 France
11.2.10.1 France Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
11.2.10.2 France Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.2.10.2.1 France Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.2.10.3 France Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
11.2.10.4 France Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11.2.10.5 France Superdisintegrants Market, Revenue and Forecast to 2027, by Application (US$ Mn)
11.2.11 Spain
11.2.11.1 Spain Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
11.2.11.2 Spain Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.2.11.2.1 Spain Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.2.11.3 Spain Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
11.2.11.4 Spain Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11.2.11.5 Spain Superdisintegrants Market, Revenue and Forecast to 2027, by Application (US$ Mn)
11.2.12 Italy
11.2.12.1 Italy Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
11.2.12.2 Italy Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.2.12.2.1 Italy Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.2.12.3 Italy Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
11.2.12.4 Italy Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11.2.12.5 Italy Superdisintegrants Market, Revenue and Forecast to 2027, by Application (US$ Mn)
11.3 Asia Pacific Superdisintegrants Market, Revenue and Forecast To 2027
11.3.1 Overview
11.3.2 Asia Pacific Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
11.3.3 Asia Pacific Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.3.3.1 Asia Pacific Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.3.4 Asia Pacific Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
11.3.5 Asia Pacific Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11.3.6 Asia Pacific Superdisintegrants Market, Revenue and Forecast to 2027, by Application (US$ Mn)
11.3.7 Asia Pacific Superdisintegrants Market, Revenue and Forecast to 2027, By Country (%)
11.3.8 China
11.3.8.1 China Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
11.3.8.2 China Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.3.8.2.1 China Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.3.8.3 China Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
11.3.8.4 China Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11.3.8.5 China Superdisintegrants Market, Revenue and Forecast to 2027, by Application (US$ Mn)
11.3.9 Japan
11.3.9.1 Japan Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
11.3.9.2 Japan Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.3.9.2.1 Japan Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.3.9.3 Japan Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
11.3.9.4 Japan Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11.3.9.5 Japan Superdisintegrants Market, Revenue and Forecast to 2027, by Application (US$ Mn)
11.3.10 India
11.3.10.1 India Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
11.3.10.2 India Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.3.10.2.1 India Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.3.10.3 India Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
11.3.10.4 India Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11.3.10.5 India Superdisintegrants Market, Revenue and Forecast to 2027, by Application (US$ Mn)
11.3.11 South Korea
11.3.11.1 South Korea Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
11.3.11.2 South Korea Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.3.11.2.1 South Korea Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.3.11.3 South Korea Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
11.3.11.4 South Korea Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11.3.11.5 South Korea Superdisintegrants Market, Revenue and Forecast to 2027, by Application (US$ Mn)
11.3.12 Australia
11.3.12.1 Australia Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
11.3.12.2 Australia Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.3.12.2.1 Australia Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.3.12.3 Australia Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
11.3.12.4 Australia Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11.3.12.5 Australia Superdisintegrants Market, Revenue and Forecast to 2027, by Application (US$ Mn)
11.4 Middle East & Africa Superdisintegrants Market, Revenue and Forecast to 2027
11.4.1 Overview
11.4.2 Middle East & Africa Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
11.4.3 Middle East & Africa Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.4.3.1 Middle East & Africa Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.4.4 Middle East & Africa Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
11.4.5 Middle East & Africa Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11.4.6 Middle East & Africa Superdisintegrants Market, Revenue and Forecast to 2027, by Application (US$ Mn)
11.4.7 Middle East & Africa Superdisintegrants Market, Revenue and Forecast to 2027, By Country (%)
11.4.8 Saudi Arabia
11.4.8.1 Saudi Arabia Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
11.4.8.2 Saudi Arabia Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.4.8.2.1 Saudi Arabia Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.4.8.3 Saudi Arabia Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
11.4.8.4 Saudi Arabia Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11.4.8.5 Saudi Arabia Superdisintegrants Market, Revenue and Forecast to 2027, by Application (US$ Mn)
11.4.9 UAE
11.4.9.1 UAE Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
11.4.9.2 UAE Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.4.9.2.1 UAE Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.4.9.3 UAE Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
11.4.9.4 UAE Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11.4.9.5 UAE Superdisintegrants Market, Revenue and Forecast to 2027, by Application (US$ Mn)
11.4.10 South Africa
11.4.10.1 South Africa Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
11.4.10.2 South Africa Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.4.10.2.1 South Africa Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.4.10.3 South Africa Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
11.4.10.4 South Africa Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11.4.10.5 South Africa Superdisintegrants Market, Revenue and Forecast to 2027, by Application (US$ Mn)
11.5 South and Central America Superdisintegrants Market, Revenue and Forecast To 2027
11.5.1 Overview
11.5.2 South and Central America Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
11.5.3 South and Central Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.5.3.1 South and Central Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.5.4 South and Central Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
11.5.5 South and Central Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11.5.6 South and Central America Superdisintegrants Market, Revenue and Forecast to 2027, by Application (US$ Mn)
11.5.7 South and Central America Superdisintegrants Market, Revenue and Forecast to 2027, By Country (%)
11.5.8 Brazil
11.5.8.1 Brazil Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
11.5.8.2 Brazil Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.5.8.2.1 Brazil Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.5.8.3 Brazil Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
11.5.8.4 Brazil Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11.5.8.5 Brazil Superdisintegrants Market, Revenue and Forecast to 2027, by Application (US$ Mn)
11.5.9 Argentina
11.5.9.1 Argentina Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
11.5.9.2 Argentina Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.5.9.2.1 Argentina Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
11.5.9.3 Argentina Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
11.5.9.4 Argentina Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11.5.9.5 Argentina Superdisintegrants Market, Revenue and Forecast to 2027, by Application (US$ Mn)
12. Superdisintegrants Market to 2027– Industry Landscape
12.1 Overview
13. Company Profiles
13.1 Ashland
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Asahi Kasei Corporation
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Avantor, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 BASF SE
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Corel Pharma Chem
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Dow DuPont Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 DFE Pharma
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Financial Overview
13.7.4 Product Portfolio
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 JRS Pharma
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 MERCK KGAA
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Roquette Frères
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 2. North America Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 3. North America Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 4. North America Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 5. North America Superdisintegrants Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 6. US Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 7. US Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 8. US Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 9. US Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 10. US Superdisintegrants Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 11. Canada Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 12. Canada Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 13. Canada Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 14. Canada Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 15. Canada Superdisintegrants Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 16. Mexico Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 17. Mexico Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 18. Mexico Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 19. Mexico Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 20. Mexico Superdisintegrants Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 21. Europe Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 22. Europe Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 23. Europe Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 24. Europe Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 25. Europe Superdisintegrants Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 26. Germany Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 27. Germany Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 28. Germany Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 29. Germany Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 30. Germany Superdisintegrants Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 31. UK Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 32. UK Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 33. UK Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 34. UK Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 35. UK Superdisintegrants Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 36. France Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 37. France Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 38. France Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 39. France Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 40. France Superdisintegrants Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 41. Spain Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 42. Spain Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 43. Spain Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 44. Spain Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 45. Spain Superdisintegrants Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 46. Italy Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 47. Italy Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 48. Italy Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 49. Italy Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 50. Italy Superdisintegrants Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 51. Asia Pacific Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 52. Asia Pacific Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 53. Asia Pacific Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 54. Asia Pacific Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 55. Asia Pacific Superdisintegrants Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 56. China Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 57. China Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 58. China Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 59. China Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 60. China Superdisintegrants Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 61. Japan Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 62. Japan Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 63. Japan Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 64. Japan Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 65. Japan Superdisintegrants Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 66. India: R&D spending of Pharmaceutical Companies (2010 & 2017)
Table 67. India Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 68. India Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 69. India Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 70. India Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 71. India Superdisintegrants Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 72. R&D Expenditure of Local Pharmaceutical Companies (2018)
Table 73. South Korea Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 74. South Korea Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 75. South Korea Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 76. South Korea Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 77. South Korea Superdisintegrants Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 78. Australia Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 79. Australia Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 80. Australia Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 81. Australia Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 82. Australia Superdisintegrants Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 83. Middle East & Africa Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 84. Middle East & Africa Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 85. Middle East & Africa Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 86. Middle East & Africa Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 87. Middle East & Africa Superdisintegrants Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 88. Saudi Arabia Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 89. Saudi Arabia Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 90. Saudi Arabia Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 91. Saudi Arabia Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 92. Saudi Arabia Superdisintegrants Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 93. UAE Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 94. UAE Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 95. UAE Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 96. UAE Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 97. UAE Superdisintegrants Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 98. South Africa Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 99. South Africa Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 100. South Africa Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 101. South Africa Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 102. South Africa Superdisintegrants Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 103. South and Central Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 104. South and Central Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 105. South and Central Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 106. South and Central Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 107. South and Central America Superdisintegrants Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 108. Brazil Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 109. Brazil Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 110. Brazil Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 111. Brazil Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 112. Brazil Superdisintegrants Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 113. Argentina Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 114. Argentina Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 115. Argentina Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 116. Argentina Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 117. Argentina Superdisintegrants Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 118. Recent Organic Growth Strategies in the Superdisintegrants Market
Table 119. Glossary of Terms, Superdisintegrants Market
LIST OF FIGURES
Figure 1. Superdisintegrants Market Segmentation
Figure 2. Superdisintegrants Segmentation, By Region
Figure 3. Global Superdisintegrants Market Overview
Figure 4. Synthetic Superdisintegrants Segment Held Largest Share Of Type Segment In Superdisintegrants Market
Figure 5. Asia Pacific Region Is Expected To Show Remarkable Growth During The Forecast Period
Figure 6. Global Superdisintegrants Market, By Geography (US$ Mn)
Figure 7. Global Superdisintegrants Market- Leading Country Markets (US$ Mn)
Figure 8. Superdisintegrants Market in North America: PEST Analysis
Figure 9. Superdisintegrants Market in Europe: PEST Analysis
Figure 10. Superdisintegrants Market In APAC: PEST Analysis
Figure 11. Superdisintegrants Market MEA: PEST Analysis
Figure 12. Superdisintegrants Market – South And Central America PEST Analysis
Figure 13. Superdisintegrants Market Impact Analysis of Drivers and Restraints
Figure 14. Global Superdisintegrants Market – Revenue Forecast And Analysis – 2018- 2027
Figure 15. Global Superdisintegrants Market – By Geography Forecast And Analysis – 2018- 2027
Figure 16. Market Positioning Of Key Player In Global Superdisintegrants Market
Figure 17. Global Superdisintegrants, By Type, 2019 & 2027 (% Share)
Figure 18. Global Synthetic Superdisintegrants Market Revenue and Forecast to 2027 (US$ Mn)
Figure 19. Global Crospovidone Market Revenue and Forecast to 2027 (US$ Mn)
Figure 20. Global Modified Starch Market Revenue and Forecast to 2027 (US$ Mn)
Figure 21. Global Modified Cellulose Market Revenue and Forecast to 2027 (US$ Mn)
Figure 22. Global Calcium Silicates Market Revenue and Forecast to 2027 (US$ Mn)
Figure 23. Global Ion Exchange Resins Market Revenue and Forecast to 2027 (US$ Mn)
Figure 24. Global Natural Superdisintegrants Market Revenue and Forecast to 2027 (US$ Mn)
Figure 25. Global Other Superdisintegrants Market Revenue and Forecast to 2027 (US$ Mn)
Figure 26. Global Superdisintegrants Market, By Formulation, 2019 & 2027 (% Share)
Figure 27. Global Tablets Market Revenue And Forecast To 2027 (US$ Mn)
Figure 28. Global Capsules Market Revenue And Forecast To 2027 (US$ Mn)
Figure 29. Global Superdisintegrants Market, By Therapeutic Area, 2019 & 2027 (% Share)
Figure 30. Global Neurological Diseases Market Revenue And Forecast To 2027 (US$ Mn)
Figure 31. Global Gastrointestinal Market Revenue And Forecast To 2027 (US$ Mn)
Figure 32. Global Oncology Market Revenue And Forecast To 2027 (US$ Mn)
Figure 33. Global Inflammatory Diseases Market Revenue And Forecast To 2027 (US$ Mn)
Figure 34. Global Infectious Diseases Market Revenue And Forecast To 2027 (US$ Mn)
Figure 35. Global Cardiovascular Diseases Market Revenue And Forecast To 2027 (US$ Mn)
Figure 36. Global Others Market Revenue And Forecast To 2027 (US$ Mn)
Figure 37. Global Superdisintegrants Market, By Application, 2019 & 2027 (% Share)
Figure 38. Global Pharmaceuticals Market Revenue And Forecast To 2027 (US$ Mn)
Figure 39. Global Nutraceuticals Market Revenue And Forecast To 2027 (US$ Mn)
Figure 40. North America Superdisintegrants Market, Revenue by Country (2018) (US$ Mn)
Figure 41. North America Superdisintegrants Market Revenue and Forecast to 2027 (US$ Mn)
Figure 42. North America Superdisintegrants Market, Revenue and Forecast to 2027, By Country (%)
Figure 43. US Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 44. Canada Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 45. Mexico Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 46. Europe Superdisintegrants Market, Revenue by Country (2019) (US$ Mn)
Figure 47. Europe Superdisintegrants Market Revenue and Forecast to 2027 (US$ Mn)
Figure 48. Europe Superdisintegrants Market, Revenue and Forecast to 2027, By Country (%)
Figure 49. Germany Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 50. UK Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 51. France Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 52. Spain Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 53. Italy Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 54. Asia Pacific Superdisintegrants Market, Revenue By Country (2019) (US$ Mn)
Figure 55. Asia Pacific Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 56. Asia Pacific Superdisintegrants Market, Revenue and Forecast to 2027, By Country (%)
Figure 57. China Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 58. Japan Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 59. India Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 60. South Korea Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 61. Australia Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 62. Middle East & Africa Superdisintegrants Market, Revenue by Country (2019) (US$ Mn)
Figure 63. Middle East & Africa Superdisintegrants Market Revenue and Forecast to 2027 (US$ Mn)
Figure 64. Middle East & Africa Superdisintegrants Market, Revenue and Forecast to 2027, By Country (%)
Figure 65. Saudi Arabia Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 66. UAE Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 67. South Africa Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 68. South and Central America Superdisintegrants Market, Revenue By Country (2019) (US$ Mn)
Figure 69. South and Central America Superdisintegrants Market Revenue and Forecast to 2027 (US$ Mn)
Figure 70. South and Central America Superdisintegrants Market, Revenue and Forecast to 2027, By Country (%)
Figure 71. Brazil Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 72. Argentina Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
The List of Companies - Superdisintegrants Market
- Ashland Inc.,
- Basf SE
- DowDupont
- JRS Pharma
- DFE Pharma
- Roquette
- Asahi Kasei Corporation
- Merck KGAA
- Corel Pharma Chem
- Avantor Performance Materials, LLC.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Superdisintegrants Market
Feb 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Feb 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Feb 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Feb 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Feb 2020
Drug Delivery Market
Forecast to 2028 - Global Analysis By Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug Delivery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End User (Hospitals and Clinics, Home Care Settings, and Other End User)